Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil slows down keratinocyte growth without being toxic.

A patient with zinc depletion improved after zinc supplementation during parenteral nutrition.

Porokeratotic eccrine and hair follicle nevus is a very rare skin disorder possibly caused by a GJB2 gene mutation.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Polysaccharides have many health benefits and are used in drugs, but isolating and purifying them is complex and requires careful methods.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

No treatment fully prevents hair loss from chemotherapy yet.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Different factors like pH, gel type, and chemical enhancers affect how well hydrocortisone gets into hair follicles, and less hydrated skin doesn't work well with the test method.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

New nano composite helps reduce scars and regrow hair during burn wound healing.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.